SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-025466
Filing Date
2018-01-30
Accepted
2018-01-30 16:14:04
Documents
4
Period of Report
2018-01-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d526591d8k.htm 8-K 16892
2 EX-1.1 d526591dex11.htm EX-1.1 209732
3 EX-5.1 d526591dex51.htm EX-5.1 8540
4 GRAPHIC g526591g0130085756177.jpg GRAPHIC 2524
  Complete submission text file 0001193125-18-025466.txt   240084
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36500 | Film No.: 18559247
SIC: 2834 Pharmaceutical Preparations